glp 1 receptor agonist heart failure The cardiovascular effects of GLP-1 agonists beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1 Receptor Agonists in Heart
Description
These side effects were predominantly mild to moderate in severity and occurred most frequently during the initial dose-escalation period, typically improving with continued treatment
doi: 10.1016/j.rbmo.2014.02.011 98 ZhouLQuHYangLShouL
The primary safety risks come from unverified suppliers offering untested products, incorrect concentrations, or contaminated peptides
Those are the main side effects
For patients with Crohn's disease who require weight management but cannot tolerate or are unsuitable for GLP-1 receptor agonists, several alternative approaches are available, aligned with NICE guidance on obesity management (CG189)
On day 1, each mouse was administered an IP dose of either vehicle or GIPR-Ab/GLP-1 at a dosage of 10 nmol kg 1
